Evidence map›Paper›PMID 36167544›Full record

ArticleJournal of neuroinflammation2022

Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimer's disease pathology and in human post-mortem brain samples.

Marie-Kim St-Pierre, Micaël Carrier, Fernando González Ibáñez, Eva Šimončičová, Marie-Josée Wallman, Luc Vallières, Martin Parent, Marie-Ève Tremblay

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 74 citations in OpenAlex.

  1. Glial cells in neuropathic pain.Physiological reviews · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. The Hallmarks of Ageing in Microglia.Cellular and molecular neurobiology · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Marie-Kim St-PierreAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.
Micaël CarrierAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.
Fernando González IbáñezDepartment of Molecular Medicine, Université Laval, Québec City, QC, Canada.
Eva ŠimončičováDivision of Medical Sciences, University of Victoria, Victoria, BC, Canada.
Marie-Josée WallmanDépartement de Psychiatrie et de Neurosciences, Faculté de Médecine, Université Laval, Quebec, QC, Canada.
Luc VallièresAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.
Martin ParentDépartement de Psychiatrie et de Neurosciences, Faculté de Médecine, Université Laval, Quebec, QC, Canada.
Marie-Ève TremblayAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada. evetremblay@uvic.ca.
Université Laval · CAUniversity of Victoria · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A diverse heterogeneity of microglial cells was previously described in Alzheimer's disease (AD) pathology, including dark microglia, a state characterized by ultrastructural markers of cellular stress. To provide novel insights into the roles of dark microglia during aging in the context of AD pathology, we performed a quantitative density and ultrastructural analysis of these cells using high-throughput scanning electron microscopy in the ventral hippocampus CA1 stratum lacunosum-moleculare of 20-month-old APP-PS1 vs C57BL/6J male mice. The density of dark microglia was significantly higher in APP-PS1 vs C57BL/6J mice, with these cells accounting for nearly half of all microglia observed near amyloid-beta (Aβ) plaques. This dark microglial state interacted more with dystrophic neurites compared to other APP-PS1 microglia and possessed glycogen granules, associated with a metabolic shift toward glycolysis, which provides the first ultrastructural evidence of their presence in microglia. Dark microglia were further observed in aging human post-mortem brain samples showing similar ultrastructural features as in mouse. Overall, our results provide a quantitative ultrastructural characterization of a microglial state associated with cellular stress (i.e., dark microglia) that is primarily restricted near Aβ plaques and dystrophic neurites. The presence of this microglial state in the aging human post-mortem brain is further revealed.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsBrainDisease Models, AnimalGlycogenHumansInfantMaleMiceMice, Inbred C57BLMice, TransgenicMicrogliaPlaque, AmyloidAmyloid beta-PeptidesAmyloid beta-Protein PrecursorGlycogenAlzheimer’s diseaseAmyloid-betaDark microgliaDystrophic neuritesHuman post-mortem brain samplesMicrogliaUltrastructure

Identifiers

PMID36167544
PMCPMC9513936
OpenAlexW4297425777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.